Epoch Biodesign Secures £14,320,000 for Sustainable Innovation
In a world increasingly focused on sustainability, Epoch Biodesign is revolutionizing the recycling industry and drawing the attention of savvy investors. This London-based company has successfully secured an impressive £14,320,000 ($18.3 million) in Series A funding, coupled with a £1 million grant from the UK government. With notable funders like Extantia Capital, Inditex, and Lowercarbon Capital on board, this funding round marks a significant milestone for the company and positions them for explosive growth.
Epoch Biodesign is not just another startup; it is spearheaded by innovative technologies that harness the power of AI, robotic automation, and advanced synthetic biology.
Under the leadership of CEO and Founder Jacob Nathan, the company is engineering enzymes designed to convert waste plastics into superior chemicals, making recycled materials more affordable and effective than their virgin counterparts. With a robust plan to use the £14.3 million raised strategically, Epoch aims to expand operations and refine its product development.
Looking ahead, the company has ambitious goals, planning to process tens of thousands of tonnes of waste plastic by 2028. Additionally, Epoch boasts over 40 partnerships across various sectors including performance apparel and luxury fashion, highlighting the vast potential of their innovative solutions. As they continue to gain traction and attract investments, Epoch Biodesign is undoubtedly a startup to watch for those interested in the future of sustainable materials and innovative funding opportunities in the green economy.
Key Terms Explained
- Series A funding
- This is the first round of financing given to a new business after it has received seed capital. Investors expect significant return from businesses, with a strategy to exit the deal within 3-5 years.
- AI, robotic automation, and advanced synthetic biology
- These are key technologies in high tech industry. AI is artificial intelligence mimicing human thoughts, robotic automation is automating tasks previously done by humans, and synthetic biology is creating and designing new biological parts and systems.
- Sustainable materials
- These are materials that are produced in a way that is environmentally friendly, often through recycling or renewable resources. These materials are gaining in popularity as businesses and consumers become more environmentally conscious.
Frequently Asked Questions
- What series of funding did Epoch Biodesign recently secure and what was the amount?-Epoch Biodesign successfully secured Series A funding amounting to £14,320,000.
- What distinguishable technologies does Epoch Biodesign utilize?+
- What are the primary goals of Epoch Biodesign in light of their funding?+
- What are the future plans of Epoch Biodesign regarding waste plastic processing?+
- Which notable investors are on board with Epoch Biodesign?+
They've invested in Epoch Biodesign
Get to know these Greentech investors
| Investors | Investment Focus | Startup Investments | Round Size | Connect |
|---|---|---|---|---|
 Inditex( ) | ||||
| All investors | All investor sectors | All funded startups | All funding rounds |
Click here for a full list of 7,589+ startup investors in the UK